Optimization of antibiotic use in hospitals - Antimicrobial stewardship and the EU Project ABS International

Chemotherapy

Volumn 54, Issue 4, 2008, Pages 260-267

  Allerberger, Franz ^a,b   Lechner, Arno ^a   Wechsler Fördös, Agnes ^a   Gareis, Roland ^a  

^a Roland Gareis Consulting   (Austria)

^b AUSTRIAN AGENCY FOR HEALTH AND FOOD SAFETY   (Austria)

Author keywords

Antibiotics; Antimicrobials; Project; Resistance; Stewardship

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; DRUG SURVEILLANCE PROGRAM; DRUG USE; DRUG UTILIZATION; EUROPE; HOSPITAL PLANNING; HOSPITAL UTILIZATION; INFECTION CONTROL; PRIORITY JOURNAL; REVIEW;

ANTI-BACTERIAL AGENTS; EUROPEAN UNION; HOSPITALS; HUMANS; PUBLIC HEALTH;

EID: 45349088620     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000149716     Document Type: Review

References (33)

1. McLoughlin A, O'Morain C: Effectiveness of antiinfectives. Chemotherapy 2005;51:243-246.
2. Raveh D, Yinnon AM, Broide E, Rudensky B: Susceptibilities of ESCL-producing Enterobacteriaceae to ertapenem, meropenem and piperacillin-tazobactam with and without clavulanic acid. Chemotherapy 2007;53:185-189.
3. Tenover FC, Hughes JM: The challenges of emerging infectious diseases. Development and spread of multiply-resistant bacterial pathogens. JAMA 1996;275:300-304.
4. Wise R: Antimicrobial resistance: paradox, actions and economics. J Antimicrob Chemother 2006;57:1189-1196.
5. Anonymous: Council Recommendation of 15 November 2001 on the prudent use of antimicrobial agents in human medicine (2002/77/EC). OJEU 2002;45:13-16.
6. Gould IM: Stewardship of antibiotic use and resistance surveillance: the international scene. J Hosp Infect 1999;43:S253-S260.
7. MacDougall C, Polk ER: Antimicrobial Stewardship Programs in Health Care Systems. Clin Microbiol Rev 2005;18:638-656.
8. Dellit TH, Owens RC, McGowan JE, Gerding DN, Weinstein RA, Burke JP, Huskins WC, Paterson DL, Fishman NO, Carpenter CF, Brennan PJ, Billeter M, Hooton TM: Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007;44:159-177.
9. Allerberger F, Gareis R, Janata O, Koller W, Lechner A, Mittermayer H, Pecnik I, Reisinger E, Rotter-leBeau M, Wechsler-Fördös A, Zuchi D: ABS Projekt Leitlinien zur Weiterentwicklung der Antibiotika-Kultur in Krankenanstalten. Vienna, Bundesministerium für Arbeit, Gesundheit und Soziales, 1998.
10. Allerberger F, Gareis R, Janata O, Koller W, Lechner A, Mittermayer H, Pecnik L, Reisinger E, Rotter-leBeau M, Wechsler-Fördös A, Zuchi D: The ABS Project:guidelines to further develop and define antibiotic use in hospitals. Vienna, Federal Ministry for Social Security and Generations, 2000, www.antibiotika-strategien.at.
11. Allerberger F, Gareis R, Janata O, Krause R, Meusburger S, Mittermayer H, Rotter-le-Beau M, Watschinger R, Wechsler-Fördös A: ABS Projekt Leitlinien zur Weiterentwicklung der Antibiotika-Kultur in Krankenanstalten. ed 2, revised. Vienna, Bundesministerium für soziale Sicherheit und Generationen, 2002.
12. Woodward RS, Medoff G, Smith MD, Gray JL: Antibiotic cost savings from formulary restrictions and physician monitoring in a medical-school-affiliated hospital. Am J Med 1987;83:817-823.
13. Coleman RW, Rodondi LC, Kaubisch S, Granzella NB, O'Hanley PD: Cost-effectiveness of prospective and continuous parenteral antibiotic control: experience at the Palo Alto Veterans Affairs Medical Center from 1987 to 1989. Am J Med 1991;90:439-444.
14. Maswoswe JJ, Okpara AU: Enforcing a policy for restricting antimicrobial drug use. Am J Health Syst Pharm 1995;52:1433-1435.
15. White AC, Atmar RL, Wilson J, Cate TR, Stager CE, Greenberg SB: Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes. Clin Infect Dis 1997;25:230-239.
16. MacKenzie FM, Monnet DL, Gould IM, ARPAC Steering Group: Relationship between the number of different antibiotics used and the total use of antibiotics in European hospitals. J Antimicrob Chemother 2006;58:657-660.
17. May AK, Melton SM, McGwin G, Cross JM, Moser SA, Rue LW: Reduction of vancomycin-resistant enterococcal infections by limitation of broad-spectrum cephalosporin use in a trauma and burn intensive care unit. Shock 2000;14:259-264.
18. Anatomical therapeutic chemical (ATC) classification index with defined daily doses (DDDs). Oslo, WHO Collaborating Center for Drug Statistics Methodology, 2005, http://www.whocc.no/atcddd/ or http://www.escmid.org/sites/ index_f.aspx?par=2.5
19. White AC, Atmar RL, Wilson J, Cate TR, Stager CE, Greenberg SB: Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes. Clin Infect Dis 1997;25:230-239.
20. Gould IM: Minimum antibiotic stewardship measures. Clin Microbiol Infect 2001;7(suppl 6):22-26.
21. Holmes WF: Conflicts of interest between the prescriber, the regulator and the profit maker. Clin Microbiol Infect 2001;7(suppl 6):9-11.
22. Marrie TJ, Lau CY, Wheeler SL, Wong CJ, Vandervoort MK, Feagan BG: A controlled trial of a critical pathway for treatment of community-acquired pneumonia. JAMA 2000;283:749-755.
23. Price J, Ekleberry A, Grover A, Melendy S, Baddam K, McMahon J, Villalba M, Johnson M, Zervos MJ: Evaluation of clinical practice guidelines on outcome of infection in patients in the surgical intensive care unit. Crit Care Med 1999;27:2118-2124.
24. Scottish Intercollegiate Guideline Network: Antibiotic Prophylaxis in Surgery. A National Clinical Guideline. Edinburgh, SIGN, 2000, SIGN Pub No 45.
25. Madaras-Kelly K: Optimizing antibiotic use in hospitals:the role of population-based antibiotic surveillance in limiting antibiotic resistance. Insights from the society of infectious diseases pharmacists. Pharmacotherapy 2003;23:1627-1673.
26. Interagency Task Force on Antimicrobial Resistance: A public health action plan to combat antimicrobial resistance. I. Domestic issues. Atlanta, Centers for Disease Control and Prevention, 2001, pp 1-43, http://www.cdc.gov/ drugresistance/actionplan/index.htm.
27. Shlaes DM, Gerding DN, John JF Jr, Craig WA, Bornstein DL, Duncan RA, Eckman MR, Farrer WE, Greene WH, Lorian V, Levy S, McGowan JE Jr, Paul SM, Ruskin J, Tenover FC, Watanakunakorn C: Society for Health Care Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance:guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis 1997;25:584-599.
28. Monnet DL: ABC Calc - Antibiotic consumption calculator [Microsoft® Excel application], version 3.0. Copenhagen, Statens Serum Institute, 2005, http://www.ssi.dk/sw379.asp.
29. Gross R, Morgan AS, Kinky DE, Weiner M, Gibson GA, Fishman NO: Impact of a hospital-based antimicrobial management program on clinical and economic outcomes. Clin Infect Dis 2001;33:289-295.
30. Struelens MJ: Multidisciplinary antimicrobial management teams: the way forward to control antimicrobial resistance in hospitals. Curr Opin Infect Dis 2003;16:305-307.
31. Rybak MJ: Antimicrobial stewardship. Pharmacotherapy 2007;27:131S-135S.
32. Metlay JP, Shea JA, Crossette LB, Asch DA: Tensions in antibiotic prescribing: pitting social concerns against the interests of individual patients. J Gen Intern Med 2002;17:87-94.
33. Bronzwaer S, Lönnroth A, Haigh R: The European Community strategy against antimicrobial resistance. Euro Surveill 2004;9:30-34.